Phillip L. Johnson

Phillip L. Johnson

Auto-generated profile, based on publicly available information

Phillip L. Johnson

Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN 46202, USA

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2009 in Nature Medicine
Verified
Journal Article
Open access
PDF file
PJPhilip L Johnson
Philip L Johnson
WTWilliam Truitt
William Truitt
SFStephanie D Fitz
Stephanie D Fitz
PMPamela E Minick
Pamela E Minick
ADAmy Dietrich
Amy Dietrich
ASAnantha Shekhar
Anantha Shekhar
Orexin, a neuropeptide best known for its role in arousal and its absence in people with narcolepsy, is also involved in the pathophysiology of panic anxiety disorder. Panic disorder is a severe anxiety disorder with recurrent, debilitating panic attacks. In individuals with panic disorder there is evidence of decreased central γ-aminobutyric acid (GABA) activity as well as marked increases in autonomic and respiratory responses after intravenous infusions of hypertonic sodium lactate1,2,3. In a rat model of panic disorder, chronic inhibition of GABA synthesis in the dorsomedial-perifornical hypothalamus of rats produces anxiety-like states and a similar vulnerability to sodium lactate–induced cardioexcitatory responses4,5,6,7,8,9. The dorsomedial-perifornical hypothalamus is enriched in neurons containing orexin (ORX, also known as hypocretin)10, which have a crucial role in arousal10,11, vigilance10 and central autonomic mobilization12, all of which are key components of panic. Here we show that activation of ORX-synthesizing neurons is necessary for developing a panic-prone state in the rat panic model, and either silencing of the hypothalamic gene encoding ORX (Hcrt) with RNAi or systemic ORX-1 receptor antagonists blocks the panic responses. Moreover, we show that human subjects with panic anxiety have elevated levels of ORX in the cerebrospinal fluid compared to subjects without panic anxiety. Taken together, our results suggest that the ORX system may be involved in the pathophysiology of panic anxiety and that ORX antagonists constitute a potential new treatment strategy for panic disorder.

1 January 2005 in Stress
Verified
Journal Article
Closed access
CLChristopher A. Lowry
Christopher A. Lowry
PJPhilip L. Johnson
Philip L. Johnson
AHAnders Hay-Schmidt
Anders Hay-Schmidt
JMJens Mikkelsen
Jens Mikkelsen
ASAnantha Shekhar
Anantha Shekhar
Anxiety is a complex emotional state associated with sustained heightened autonomic and behavioral arousal and an increase in avoidance behavior. Anxiety-related behavior is a form of risk assessment behavior that is associated with a level of uncertainty or unpredictability regarding the outcome of emotionally salient events, often when both rewarding and aversive outcomes are possible. In this review, we highlight recent advances in our understanding of the neural circuits regulating anxiety states and anxiety-related behavior with an emphasis on the role of brainstem serotonergic systems in modulating anxiety-related circuits. In particular, we explore the possibility that the regulation of anxiety states and anxiety-related behavior by serotonergic systems is dependent on a specific, topographically organized mesolimbocortical serotonergic system that originates in the mid-rostrocaudal and caudal parts of the dorsal raphe nucleus.

1 June 2004 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JAJolane K. Abrams
Jolane K. Abrams
PJPhilip L. Johnson
Philip L. Johnson
JHJacob H. Hollis
Jacob H. Hollis
CLChristopher A. Lowry
Christopher A. Lowry

5 June 2011 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
JBJoel M Brittain
Joel M Brittain
DDDjane B Duarte
Djane B Duarte
SWSarah M Wilson
Sarah M Wilson
WZWeiguo Zhu
Weiguo Zhu
CBCarrie Ballard
Carrie Ballard
Rajesh KhannaRajesh Khanna
Rajesh Khanna

1 January 2012
Verified
Book Chapter
Closed access
PJPhilip L. Johnson
Philip L. Johnson
AMAndrei Molosh
Andrei Molosh
SFStephanie D. Fitz
Stephanie D. Fitz
WTWilliam A. Truitt
William A. Truitt
ASAnantha Shekhar
Anantha Shekhar

1 January 2005 in Neuroscience
Verified
Journal Article
Closed access
JAJ.K. Abrams
J.K. Abrams
PJP.L. Johnson
P.L. Johnson
AHA. Hay-Schmidt
A. Hay-Schmidt
JMJ.D. Mikkelsen
J.D. Mikkelsen
ASA. Shekhar
A. Shekhar
CLC.A. Lowry
C.A. Lowry